Ca2+-Related Signaling and Protein Phosphorylation Abnormalities Play Central Roles in a New Experimental Model of Electrical Storm

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Circulation

• Publication date

  2011-05-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.110.016683PMID 21555709
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CaV1.2 β-subunit coordinates CaMKII-triggered cardiomyocyte death and afterdepolarizations

  2010cited by this paper
• Mechanisms of recurrent ventricular fibrillation in a rabbit model of pacing-induced heart failure.

  2009cited by this paper
• The Calcium/Calmodulin/Kinase System and Arrhythmogenic Afterdepolarizations in Bradycardia-Related Acquired Long-QT Syndrome

  2009cited by this paper
• Ca/Calmodulin Kinase II Differentially Modulates Potassium Currents

  2009cited by this paper
• Recurrent ventricular arrhythmia storms in the age of implantable cardioverter defibrillator therapy: a comprehensive review.

  2008cited by this paper
• The canine model with chronic, complete atrio-ventricular block.

  2008cited by this paper
• Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation.

  2007cited by this paper
• Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy.

  2007cited by this paper
• Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart.

  2007cited by this paper
• Multiple downstream proarrhythmic targets for calmodulin kinase II: moving beyond an ion channel-centric focus.

  2007cited by this paper
• Potassium Channel Subunit Remodeling in Rabbits Exposed to Long-Term Bradycardia or Tachycardia: Discrete Arrhythmogenic Consequences Related to Differential Delayed-Rectifier Changes

  2006cited by this paper
• Increased Sarcoplasmic Reticulum Calcium Leak but Unaltered Contractility by Acute CaMKII Overexpression in Isolated Rabbit Cardiac Myocytes

  2006cited by this paper
• Ca2+/Calmodulin–Dependent Protein Kinase Modulates Cardiac Ryanodine Receptor Phosphorylation and Sarcoplasmic Reticulum Ca2+ Leak in Heart Failure

  2005cited by this paper
• PKC-α regulates cardiac contractility and propensity toward heart failure

  2004cited by this paper
• Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts.

  2004cited by this paper
• PKC-alpha regulates cardiac contractility and propensity toward heart failure.

  2004cited by this paper
• Calcium handler mishandles heart

  2004cited by this paper
• Ca2+/Calmodulin-Dependent Protein Kinase II Phosphorylation Regulates the Cardiac Ryanodine Receptor

  2004cited by this paper
• Transgenic CaMKII C Overexpression Uniquely Alters Cardiac Myocyte Ca

  2003cited by this paper
• The &dgr;C Isoform of CaMKII Is Activated in Cardiac Hypertrophy and Induces Dilated Cardiomyopathy and Heart Failure

  2003cited by this paper
• Transgenic CaMKII&dgr;C Overexpression Uniquely Alters Cardiac Myocyte Ca2+ Handling: Reduced SR Ca2+ Load and Activated SR Ca2+ Release

  2003cited by this paper
• Calmodulin Kinase II and Arrhythmias in a Mouse Model of Cardiac Hypertrophy

  2002cited by this paper
• Ionic Mechanisms of Acquired QT Prolongation and Torsades de Pointes in Rabbits With Chronic Complete Atrioventricular Block

  2002cited by this paper
• Dual site phospholamban phosphorylation and its physiological relevance in the heart.

  2002cited by this paper
• Electrical Storm Presages Nonsudden Death: The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial

  2001cited by this paper
• Dilated Cardiomyopathy and Sudden Death Resulting From Constitutive Activation of Protein Kinase A

  2001cited by this paper
• PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.

  2000cited by this paper
• Systemic administration of calmodulin antagonist W-7 or protein kinase A inhibitor H-8 prevents torsade de pointes in rabbits.

  1999cited by this paper
• KN-93, an inhibitor of multifunctional Ca++/calmodulin-dependent protein kinase, decreases early afterdepolarizations in rabbit heart.

  1998cited by this paper
• Ventricular fibrillation-induced intracellular Ca2+ overload causes failed electrical defibrillation and post-shock reinitiation of fibrillation.

  1998cited by this paper
• Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations.

  1993cited by this paper
• Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity.

  1991cited by this paper
• Cell calcium in the pathophysiology of ventricular fibrillation and in the pathogenesis of postarrhythmic contractile dysfunction.

  1989cited by this paper

• TRPV2 Inhibition Prevents Right Ventricular Remodeling and Arrhythmia in Experimental Pulmonary Hypertension

  2025cites this paper
• Long-term outcomes of ventricular tachycardia ablation in patients presenting with electrical storm

  2025cites this paper
• Mechanisms of torsades de pointes: an update

  2024cites this paper
• Stellate ganglion block therapy in management of ventricular electrical storm: A case report

  2024cites this paper
• Management of patients with an electrical storm or clustered ventricular arrhythmias: a clinical consensus statement of the European Heart Rhythm Association of the ESC—endorsed by the Asia-Pacific Heart Rhythm Society, Heart Rhythm Society, and Latin-American Heart Rhythm Society

  2024cites this paper
• An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor

  2023cites this paper
• Effect of Digitalis on ICD or CRT-D Recipients: A Systematic Review and Meta-Analysis

  2023cites this paper
• Novel Biosensor Identifies Ruxolitinib as a Potent and Cardioprotective CaMKII Inhibitor

  2022cites this paper
• Early Catheter Ablation Versus Initial Medical Therapy for Ventricular Tachycardia Storm

  2022cites this paper
• Implantable cardioverter-defibrillator therapy in primary versus secondary prevention: Reliable prediction of appropriate therapies and mortality is still an unmet need

  2021cites this paper
• Rotors anchored by refractory islands drive Torsades de Pointes in an experimental model of electrical storm.

  2021cites this paper
• Recent insights into mechanisms and clinical approaches to electrical storm.

  2021cites this paper
• Electrical Storm.

  2021cites this paper
• Function and regulation of phosphatase 1 in healthy and diseased heart.

  2021cites this paper
• Successful Refractory of Acute Myocardial Infarction-induced Electrical Storm by Defibrillations and Amiodarone: A Case Report

  2020cites this paper
• Management of ventricular electrical storm: a contemporary appraisal.

  2020cites this paper
• Contemporary Management of Electrical Storm.

  2019cites this paper
• Management of Ventricular Storm with Thoracic Epidural Anesthesia

  2019cites this paper
• Prognostic impact of electrical storm in patients with implantable cardioverter defibrillators: Mechanistic and therapeutic considerations to reduce the risk of death.

  2018cites this paper
• Essential role of ryanodine receptor 2 phosphorylation in the effect of azumolene on ventricular arrhythmia vulnerability in a rabbit heart model

  2018cites this paper
• Electrical storm: mechanistic and therapeutic considerations to avoid death in the survivors.

  2018cites this paper
• Modernized Classification of Cardiac Antiarrhythmic Drugs

  2018cites this paper
• Non-ion channel therapeutics for heart failure and atrial fibrillation: Are CaMKII inhibitors ready for clinical use?

  2018cites this paper
• Improvement of cardiomyocyte function by a novel pyrimidine-based CaMKII-inhibitor.

  2018cites this paper
• 113 – Innovations in Antiarrhythmic Drug Therapy

  2018cites this paper
• Identification of a novel cAMP dependent protein kinase A phosphorylation site on the human cardiac calcium channel

  2017cites this paper
• Beyond the Storm: Comparison of Clinical Factors, Arrhythmogenic Substrate, and Catheter Ablation Outcomes in Structural Heart Disease Patients With versus Those Without a History of Ventricular Tachycardia Storm

  2017cites this paper
• Reduction of SR Ca2+ leak and arrhythmogenic cellular correlates by SMP-114, a novel CaMKII inhibitor with oral bioavailability

  2017cites this paper
• Effect of GWAS-Identified Genetic Variants on Maximum QT Interval in Patients With Schizophrenia Receiving Antipsychotic Agents: A 24-Hour Holter ECG Study

  2017cites this paper
• in Vivo Post–cardiac arrest Myocardial Dysfunction is supported by ca 2+ /calmodulin-Dependent Protein Kinase ii–Mediated calcium long-term Potentiation and Mitigated by alda-1, an agonist of aldehyde Dehydrogenase type 2

  2016cites this paper
• In Vivo Post–Cardiac Arrest Myocardial Dysfunction Is Supported by Ca2+/Calmodulin-Dependent Protein Kinase II–Mediated Calcium Long-Term Potentiation and Mitigated by Alda-1, an Agonist of Aldehyde Dehydrogenase Type 2

  2016cites this paper
• Risk factors and prognostic role of an electrical storm in patients after myocardial infarction with an implanted ICD for secondary prevention

  2016cites this paper
• The link between abnormal calcium handling and electrical instability in acquired long QT syndrome--Does calcium precipitate arrhythmic storms?

  2016cites this paper
• In vivo Post-cardiac arrest myocardial dysfunction is supported by CaMKII-mediated calcium long-term potentiation and mitigated by Alda-1 , an Agonist of Aldehyde Dehydrogenase Type 2 Running Title : Post-cardiac arrest myocardial dysfunction

  2016cites this paper
• in Vivo Post–cardiac arrest Myocardial Dysfunction is supported by ca 2+ /calmodulin-Dependent Protein Kinase ii–Mediated calcium long-term Potentiation and Mitigated by alda-1, an agonist of aldehyde Dehydrogenase type 2

  2016cites this paper
• in Vivo Post–cardiac arrest Myocardial Dysfunction is supported by ca 2+ /calmodulin-Dependent Protein Kinase ii–Mediated calcium long-term Potentiation and Mitigated by alda-1, an agonist of aldehyde Dehydrogenase type 2

  2016cites this paper
• in Vivo Post–cardiac arrest Myocardial Dysfunction is supported by ca 2+ /calmodulin-Dependent Protein Kinase ii–Mediated calcium long-term Potentiation and Mitigated by alda-1, an agonist of aldehyde Dehydrogenase type 2

  2016cites this paper
• in Vivo Post–cardiac arrest Myocardial Dysfunction is supported by ca 2+ /calmodulin-Dependent Protein Kinase ii–Mediated calcium long-term Potentiation and Mitigated by alda-1, an agonist of aldehyde Dehydrogenase type 2

  2016cites this paper
• in Vivo Post–cardiac arrest Myocardial Dysfunction is supported by ca 2+ /calmodulin-Dependent Protein Kinase ii–Mediated calcium long-term Potentiation and Mitigated by alda-1, an agonist of aldehyde Dehydrogenase type 2

  2016cites this paper
• Systematic Review/Meta-analysis A Systematic Review and Meta-analysis of the Association Between Implantable Cardioverter-Defibrillator Shocks and Long-term Mortality

  2015cites this paper
• A systematic review and meta-analysis of the association between implantable cardioverter-defibrillator shocks and long-term mortality.

  2015cites this paper
• Role of sodium and calcium dysregulation in tachyarrhythmias in sudden cardiac death.

  2015cites this paper
• Experimental antiarrhythmic targets: CaMKII inhibition - ready for clinical evaluation?

  2014cites this paper
• Cardiac Arrest Arrhythmias

  2014cites this paper
• 106 – Atrioventricular Block

  2014cites this paper
• 112 – New Antiarrhythmic Drugs and New Concepts for Old Drugs

  2014cites this paper
• Molecular mechanisms of heart failure progression associated with implantable cardioverter‐defibrillator shocks for ventricular tachyarrhythmias

  2014cites this paper
• Calcium store stability as an antiarrhythmic endpoint.

  2014cites this paper
• Signaling effectors underlying pathologic growth and remodeling of the heart.

  2013cites this paper
• Apamin‐Sensitive Calcium‐Activated Potassium Currents in Rabbit Ventricles with Chronic Myocardial Infarction

  2013cites this paper
• The promise of CaMKII inhibition for heart disease: preventing heart failure and arrhythmias

  2013cites this paper
• Luo and Anderson Mechanisms of Altered Ca 2 + Handling in Heart Failure

  2013cites this paper
• Mechanisms of Altered Ca2+ Handling in Heart Failure

  2013cites this paper
• Electrical storm: recent pathophysiological insights and therapeutic consequences

  2013cites this paper
• Mechanisms of Altered Ca 2+ Handling in Heart Failure A Challenges,

  2013cites this paper
• Mechanisms of Altered Ca 2+ Handling in Heart Failure A Challenges,

  2013cites this paper
• Mechanisms of Altered Ca 2+ Handling in Heart Failure A Challenges,

  2013cites this paper
• Mechanisms of Altered Ca 2+ Handling in Heart Failure A Challenges,

  2013cites this paper
• Mechanisms of Altered Ca 2+ Handling in Heart Failure A Challenges,

  2013cites this paper
• Histone deacetylase signaling in cardioprotection

  2013cites this paper
• Heterogeneous Upregulation of Apamin‐Sensitive Potassium Currents in Failing Human Ventricles

  2013cites this paper
• Bradycardia alters Ca(2+) dynamics enhancing dispersion of repolarization and arrhythmia risk.

  2013cites this paper
• Double-Stranded RNA Attenuates the Barrier Function of Human Pulmonary Artery Endothelial Cells

  2013cites this paper
• Insulin Alleviates Posttrauma Cardiac Dysfunction by Inhibiting Tumor Necrosis Factor-&agr;–Mediated Reactive Oxygen Species Production*

  2013cites this paper
• The multifunctional role of calcium in the heart: a tempting target

  2013cites this paper
• Nerve sprouting, defibrillation and calcium waves

  2013cites this paper
• Mechanisms of Ca2+-Triggered Arrhythmias

  2012cites this paper
• New Therapeutic Targets in Cardiology Arrhythmias and Ca 2 (cid:1) /Calmodulin-Dependent Kinase II (CaMKII)

  2012cites this paper
• The involvement of CaMKII in myocardial ischaemia-reperfusion injury

  2012cites this paper
• Catheter ablation of ventricular fibrillation triggers and electrical storm.

  2012cites this paper
• New Therapeutic Targets in Cardiology: Arrhythmias and Ca2+/Calmodulin-Dependent Kinase II (CaMKII)

  2012cites this paper
• Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias.

  2012cites this paper
• Na(+) channel I-II loop mediates parallel genetic and phosphorylation-dependent gating changes.

  2012cites this paper
• Successful management of a case of electrical storm due to invasive endocarditis.

  2012cites this paper
• Relevance of calmodulin/CaMKII activation for arrhythmogenesis in the AV block dog.

  2012cites this paper
• Mechanism underlying bradycardia and long QT 2 related arrhythmias: Interplay between Ca2+ overload and electrical dysfunction

  2011cites this paper
• CaMKII inhibition: breaking the cycle of electrical storm?

  2011cites this paper
• Current Management of Electrical Storm

  2011cites this paper
• Electrical storm and calcium signaling: a review.

  2011cites this paper
• World Journal of Cardiology

  year unknowncites this paper
• World Journal of Cardiology

  year unknowncites this paper